Gene Review:
GP - virion spike glycoprotein precursor
Zaire ebolavirus
- Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Volchkov, V.E., Feldmann, H., Volchkova, V.A., Klenk, H.D. Proc. Natl. Acad. Sci. U.S.A. (1998)
- Release of viral glycoproteins during Ebola virus infection. Volchkov, V.E., Volchkova, V.A., Slenczka, W., Klenk, H.D., Feldmann, H. Virology (1998)
- Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections. Prehaud, C., Hellebrand, E., Coudrier, D., Volchkov, V.E., Volchkova, V.A., Feldmann, H., Le Guenno, B., Bouloy, M. J. Gen. Virol. (1998)
- Functional importance of the coiled-coil of the Ebola virus glycoprotein. Watanabe, S., Takada, A., Watanabe, T., Ito, H., Kida, H., Kawaoka, Y. J. Virol. (2000)
- Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. Chan, S.Y., Speck, R.F., Ma, M.C., Goldsmith, M.A. J. Virol. (2000)
- Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Yang, Z.Y., Duckers, H.J., Sullivan, N.J., Sanchez, A., Nabel, E.G., Nabel, G.J. Nat. Med. (2000)
- Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Volchkov, V.E., Volchkova, V.A., Muhlberger, E., Kolesnikova, L.V., Weik, M., Dolnik, O., Klenk, H.D. Science (2001)
- Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. Yonezawa, A., Cavrois, M., Greene, W.C. J. Virol. (2005)
- Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs. Mellquist-Riemenschneider, J.L., Garrison, A.R., Geisbert, J.B., Saikh, K.U., Heidebrink, K.D., Jahrling, P.B., Ulrich, R.G., Schmaljohn, C.S. Virus Res. (2003)
- Molecular characterization of guinea pig-adapted variants of Ebola virus. Volchkov, V.E., Chepurnov, A.A., Volchkova, V.A., Ternovoj, V.A., Klenk, H.D. Virology (2000)
- Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway. Sullivan, N.J., Peterson, M., Yang, Z.Y., Kong, W.P., Duckers, H., Nabel, E., Nabel, G.J. J. Virol. (2005)
- Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. Noda, T., Sagara, H., Suzuki, E., Takada, A., Kida, H., Kawaoka, Y. J. Virol. (2002)
- A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge. Bukreyev, A., Yang, L., Zaki, S.R., Shieh, W.J., Rollin, P.E., Murphy, B.R., Collins, P.L., Sanchez, A. J. Virol. (2006)
- Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. Malashkevich, V.N., Schneider, B.J., McNally, M.L., Milhollen, M.A., Pang, J.X., Kim, P.S. Proc. Natl. Acad. Sci. U.S.A. (1999)
- Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. Simmons, G., Rennekamp, A.J., Chai, N., Vandenberghe, L.H., Riley, J.L., Bates, P. J. Virol. (2003)
- Detection of cell-cell fusion mediated by Ebola virus glycoproteins. Bär, S., Takada, A., Kawaoka, Y., Alizon, M. J. Virol. (2006)
- Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. Ito, H., Watanabe, S., Takada, A., Kawaoka, Y. J. Virol. (2001)
- Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. Lin, G., Simmons, G., Pöhlmann, S., Baribaud, F., Ni, H., Leslie, G.J., Haggarty, B.S., Bates, P., Weissman, D., Hoxie, J.A., Doms, R.W. J. Virol. (2003)
- GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Volchkov, V.E., Becker, S., Volchkova, V.A., Ternovoj, V.A., Kotov, A.N., Netesov, S.V., Klenk, H.D. Virology (1995)
- Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Pushko, P., Bray, M., Ludwig, G.V., Parker, M., Schmaljohn, A., Sanchez, A., Jahrling, P.B., Smith, J.F. Vaccine (2000)
- Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies. Ye, L., Lin, J., Sun, Y., Bennouna, S., Lo, M., Wu, Q., Bu, Z., Pulendran, B., Compans, R.W., Yang, C. Virology (2006)
- Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Sullivan, N.J., Geisbert, T.W., Geisbert, J.B., Xu, L., Yang, Z.Y., Roederer, M., Koup, R.A., Jahrling, P.B., Nabel, G.J. Nature (2003)
- Functional expression of mouse relaxin and mouse relaxin-3 in the lung from an Ebola virus glycoprotein-pseudotyped lentivirus via tracheal delivery. Silvertown, J.D., Walia, J.S., Summerlee, A.J., Medin, J.A. Endocrinology (2006)
- DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. Vanderzanden, L., Bray, M., Fuller, D., Roberts, T., Custer, D., Spik, K., Jahrling, P., Huggins, J., Schmaljohn, A., Schmaljohn, C. Virology (1998)